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Introduction: Phytotherapy is increasingly evident in the complex treatment o f  diseases due 
to the elucidation o f  the active compounds from plants with beneficial pharmacological effects. The 
creation o f  a scientific base on rational use o f  medicinal herbs opens new prospects for the 
pharmacotherapy improving. Therefore, the issue o f  interactions between drugs and plant drugs in 
terms o f  synergism and antagonism becomes current for arguing security and safety o f  their 
association. Data on such interactions are minor and dispersed, as they are more difficult due to the 
varied and rich content o f  active ingredients from plants. Interactions between herbs and drugs can 
be detected in pharmacotherapeutic and toxicological aspect.
Purpose and objectives: is the bibliographic study o f  the pharmacodynamic interactions 
between medical herbs and drugs, their reflection in the training process.
The results and discussion: Pharmacodynamic studies o f  herbal drugs and o f  their active 
principles have demonstrated the presence o f  a variety o f  pharmacological effects (anti-inflammatory, 
immunostimulant, antioxidant, antimicrobial, sedative, anxiolytic, antispasmodic, etc.). It was 
determined that the association with drugs can have unpredictable consequences, both therapeutic and 
toxicologic. Thus, pharmacodynamic interactions can be achieved by: drug interaction with receptors, 
allosteric modulation o f  receptor sites; influencing mediator systems (release, uptake, synthesis, 
metabolism), modifying the activity o f  enzymes, changing the activity o f  organs and systems, the 
development o f  liver, kidney disturbances etc. Thus, St. John's wort drugs manifest antidepressant 
action by inhibiting the norepinephrine, serotonin, dopamine reuptake. However, they also induce 
adverse effects in combination with antidepressants as selective inhibitor o f  the reuptake o f  these 
neurotransmitters. Valerian benzodiazepines shows the same effect by modulating the GABA - ergic 
system. Echinacea, ginseng, by their phenolic triterpenes, flavonoids, saponins, polysaccharides 
determine the immunomodulatory effect which can produce contradictory effects in patients under 
immunosuppressive organ transplantation. Garlic drugs develop multiple metabolic effects, including 
the inhibition o f  lipid-lowering hydroxy-methyl-glutaryl - CoA - reductase for stimulation o f  the 
efficiency o f  statins. The associated use o f  these compounds may increase the incidence o f 
rhabdo myolysis due to increased concentration o f  statins as a result o f  pharmacokinetic interactions. It is 
necessary to mention that the result o f  pharmacokinetic interactions, particularly produced by the 
induction and/or inhibition o f  cytochrome P-450 and transport systems will be characterized by the 
amplification and/or decrease o f  the pharmacological effects and adverse reactions.
Conclusion. The associated use o f  drugs with medicinal herbs for the treatment o f diseases requires 
strict monitoring o f  the efficiency and safety through the possible pharmacokinetic and pharmacodynamic 
interactions. The information about the consequences o f  these interactions must be brought to the attention 
o f  physicians, pharmacists and patients in order to ensure a rational pharmacotherapy.
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Introduction: The utilization on a large scale from 30 to 85% o f  basic and active compounds from 
plants according to WHO data is an actual problem o f  modem medicine due to the possible interactions 
with drugs. International bodies (WHO, FDA, EMEA, EFSA) are much concerned about the spreading of 
medical herbs marketing which do not contain a proper reference material and/or not being certified by the
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WHO. The problem becomes even more complicated due to the fact that vegetal drugs are used 
concomitantly with medicines as patients and even doctors do not always pay the necessary attention to 
this problem considering medical herbs inoffensive and not being harmful for health.
Purpose and objectives: is to analyze bibliographic data bases which refer to the significance o f 
pharmacokinetic interactions and the consequences o f  the associated use o f  vegetal drugs and medicines.
The results and discussion: Analysis o f  literature showed the existence o f  hundreds o f  
experimental and clinical studies, o f  cases referring to interactions o f  approximately 50-85 o f  
medical herbs and drugs, many o f  which demonstrate clinical significance. It was proved during this 
research that the pharmacokinetic interactions take place at different levels o f  absorption, 
distribution, metabolism and elimination. A particular interest for medical practice is the 
concomitant utilization with medicines with drugs from rattle (Hypericum perforatum), grapefruit 
0Citrus paradişi), ginseng {Panax ginseng), ginkgo biloba (Ginkgo biloba), garlic {Allium sativum), 
echinaceea {Echinacea purpurea), thistle {Silybum marianum) etc.. The most important 
pharmacokinetic interactions were reported at the level o f  the cytochrome P-450 activity and o f  the 
conveyors (P-glycoprotein etc.). It was established that the grapefruit, echinaceea, green tea, garlic, 
milk thistle, licorice, chamomile, lemon Chinese are inhibitors o f  P-450 cytochrome (CYP 1A2, 
2C9, 2C19, 2D6, 2E1, 3A4 etc.), while the Hypericum perforatum, Panax ginseng, eleuterococcus, 
rosemary, green tea, Echinaceea purpureae manifested as inductors. Some o f  the plants (echinaceea, 
green tea, ginseng etc.) had an effect on CYP 3A4 in liver and as inhibitor o f  isoenzyme 
respectively in the intestine. Recent studies showed an important influence o f  medical herbs on the 
activity o f  transporting systems, especially on P-glycoprotein, located in the intestine, liver, kidney, 
hematoencephalic barrier, placenta, testicles. The P-glycoprotein acts as an efflux pump, and its 
induction or inhibition will influence the absorption, transport and the elimination o f  drugs.
Conclusion: Medicinal herbs when used concomitantly with medicines will show pharmaco­
kinetic interactions with essential changes o f  the level o f  medicines in the body and respectively o f  
therapeutic effects. These data require adequate information given by the doctors, pharmacists and 
patients, with their detailed description in the instructions and medical literature as well.
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Introduction: According to academician A.M.Ugolev, the bacterial flora is a necessary attribute 
o f the existence o f  complex organisms. It is known that the most numerous and complicated by its 
composition population o f  bacteria is in the gastro-intestinal tract, particularly in its lower regions. There 
were made significant advances in the study o f  the intestinal microbiota and its functional role in 
humans and animals in recent decades. There is also shown that changing normal intestinal microbiota 
composition, (the so-called intestinal dysbiosis) as during the administration o f  antibiotics, leads to a 
number o f  disfunctions with severe consequences for the organism.). Literature contains very 
comprehensive information about the changes in composition o f  the bacterial flora under the influence 
o f various antibiotics. Although it has very little information about the impact these drugs have on the 
final stage o f  the digestive process, which largely determines the overall body metabolism and 
homeostasis. The purpose o f  this work was to investigate during the experiments on rats, the effects that 
Ampicilline and Metronidazole (antibiotics which are widely used in clinic) have on some indicators o f 
the general organism condition, structure o f  a small and thick intestine, and activity o f  two intestinal 
enzymes: transmembrane M aminopeptidase and predominantly o f  intracellular glycyl-L- 
leycindipeptidaze, which are carrying out final stages o f  hydrolysis o f  proteins. Also there was collected 
data about the microbiological resistance to these drugs.
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